Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Medtronic
McKinsey
Citi
UBS
Colorcon
Fuji
Cantor Fitzgerald
US Army

Generated: August 20, 2017

DrugPatentWatch Database Preview

TAGAMET HB Drug Profile

« Back to Dashboard

What is the patent landscape for Tagamet Hb, and when can generic versions of Tagamet Hb launch?

Tagamet Hb is a drug marketed by Medtech Products and Glaxosmithkline and is included in two NDAs.

The generic ingredient in TAGAMET HB is cimetidine. There are twenty-five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the cimetidine profile page.

Summary for Tradename: TAGAMET HB

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list91
Clinical Trials: see list3
Patent Applications: see list5,776
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAGAMET HB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medtech Products
TAGAMET HB
cimetidine
TABLET;ORAL020238-001Jun 19, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Medtech Products
TAGAMET HB
cimetidine
TABLET;ORAL020238-002Aug 21, 1996OTCYesYes► Subscribe► Subscribe► Subscribe
Glaxosmithkline
TAGAMET HB 200
cimetidine
SUSPENSION;ORAL020951-001Jul 9, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
US Army
Deloitte
Cerilliant
Julphar
Express Scripts
Merck
UBS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot